Disease Information for Erlotinib (Tarceva) (EGF receptor blocker) Administration/Toxicity

Ads
Disease Mechanism & Classification
Drugs
DRUG/ Source rDNA Manufacture
DRUG/Anti-neoplastic medications (examples)
DRUG/Biological response modifiers/chemoRX (example)
DRUG/Biologicals/serums/vaccines/blood products (cat)
DRUG/Chemotherapeutics/cancer drugs/etc (category)
DRUG/Cytochrome CY P450 3A4 degradation pathway
DRUG/Cytokines genetically bioengineered medication (example)
DRUG/DNA Bioengineered Antibody (Imab/Umab/Omab)
DRUG/Epithelial growth factor receptor blocker
DRUG/Genetically engineered/biological drug (example)
DRUG/Signaling Inhibitor Chemotherapy
DRUG/Tyrosine kinase inhibitor/EGF-R (Chemo)
Process
PROCESS/Medication/Drug (CONFIRM dose/before treatment)
Synonyms
Synonym
Erlotinib (Tarceva) (EGF receptor blocker) admin, Brand name/Tarceva (Erlotinib)
Treatment
Drug Dosage
DRUG/.$$$$$ Most Expensive
DRUG/2002 new drug (RX)
DRUG/Dose 100 mgm (Unit/Pill/Capsule size)
DRUG/Dose 150 mgms (Unit/Pill/Capsule size)
DRUG/Dose TID Medication
DRUG/Foreign license drug (non-USA)
DRUG/Injectable medication (parenteral)
DRUG/Oral medication (ex)
Definition

Tarceva brand of Erlotinib oral tyrosine kinase blocker; Cancer chemotherapy drug; biological response modifier for lung and ovarian cancer; Epithelial/epidermal growth factor receptor inhibitor drug; released 2005 OSI/genentech pharmaceutical; 150 mgm tid oral preparation; action by blocking intracelular phosphorylation of tyrosine kinase;interstitial lung disease major complication indicated for non small cell ca lung;avoid with ketoconazole and other CYP3A4 metabolized drugs

(Edit)

External Links Related to Erlotinib (Tarceva) (EGF receptor blocker) Administration/Toxicity
Google
Wikipedia
Merck
Images
PubMed (National Library of Medicine)
NGC (National Guideline Clearinghouse)
Medscape (eMedicine)
Harrison's Online (accessmedicine)
NEJM (The New England Journal of Medicine)
Ads